American Academy of Dermatology, Schaumburg, Illinois 60173, USA.
J Am Acad Dermatol. 2011 Jun;64(6):e105-12. doi: 10.1016/j.jaad.2010.10.029. Epub 2011 Feb 1.
Evidence-based clinical guidelines are developed to educate and inform physicians about best practices in patient care, and assist providers in the application of treatments and technologies that can improve outcomes. Clinical guidelines also aid appeal of payment decisions; serve as the basis for quality measure development, appropriateness criteria, and maintenance of certification modules; and help identify areas for further clinical research.
For guidelines to serve dermatologists effectively in these diverse roles, they must be current, varied in clinical focus, and developed with a high degree of rigor that includes attention to potential conflicts of interest.
To address these needs and keep pace with advances in medicine, the American Academy of Dermatology (AAD) recently revised the evidence-based guideline development process.
Key changes include development of a yearly needs assessment process to determine what guidelines are most needed, the development of focused guidelines that address rapidly evolving clinical topics, a formal method of vetting guidelines produced by other societies, and a scheduled reassessment of existing guidelines to ensure they provide current and practical information. The process for identifying and managing potential conflicts of interest was also revised and expanded to meet current expectations and evolving standards.
The impact of these changes to the AAD's guideline development process will not be fully realized for several years.
These changes will help ensure the AAD will be able to provide its members with continued evidence-based guidance to support patient care across the scope of dermatologic practice.
循证临床指南旨在教育和告知医生患者护理方面的最佳实践，并帮助提供者应用可改善结果的治疗方法和技术。临床指南还有助于支付决策的上诉；作为质量衡量标准制定、适宜性标准和认证模块维护的基础；并有助于确定进一步临床研究的领域。
为了使皮肤科医生在这些不同的角色中有效地使用指南，它们必须是最新的、具有不同的临床重点，并具有高度的严谨性，包括对潜在利益冲突的关注。
为了满足这些需求并跟上医学的进步，美国皮肤病学会（AAD）最近修订了循证指南制定流程。
关键变化包括制定年度需求评估流程，以确定最需要哪些指南；制定关注快速发展的临床主题的重点指南；正式审查其他学会制定的指南的方法；以及定期重新评估现有指南，以确保它们提供当前和实用的信息。还修订和扩大了识别和管理潜在利益冲突的流程，以满足当前的期望和不断发展的标准。
这些变化对 AAD 指南制定流程的影响需要几年时间才能完全体现。
这些变化将有助于确保 AAD 将能够为其成员提供持续的循证指导，以支持皮肤科实践范围内的患者护理。
